Top accelerator startups

14,448 startups · 29 programs

Indee Labs

Active · Enabling T cell immunotherapy discovery, development and manufacturing

8signal of 100 · rising 1
  • team of 5Team size · YC's directory+4
  • went through YCProgram · this site+4

A sum of public facts, not a judgement and not investment advice.

Competitors

Adjacent

Also from W17

All of W17

About Indee Labs

Intracellular delivery is the most problematic step in T cell immunotherapy discovery, development and manufacturing. Indee Labs is developing a non-viral intracellular delivery system based on microfluidic vortex shedding (µVS) to rapidly deliver nucleic acids, proteins and gene editing complexes to patient and donor T cells with minimal perturbation.

YC batch
W17 · Winter 2017
Status, per YC
Active
Category
Other
Team size
5
Location
San Francisco, CA, USA; Berkeley, CA, USA
Checked
10h ago

YC tags: Gene Therapy, Microfluidics, Cell Therapy

Indee Labs in W17: 116 companies, 24% AI

Indee Labs: questions

Which YC batch was Indee Labs in?

Indee Labs was in Y Combinator's Winter 2017 batch (W17).

Is Indee Labs still active?

Y Combinator lists Indee Labs as active.

Where is Indee Labs based?

Indee Labs lists San Francisco, CA, USA; Berkeley, CA, USA as its location on YC's directory.